[DNLI] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -131.12%
YoY- -147.24%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 4,205 125,676 1,195 1,648 641 145,149 0 -
PBT -38,992 77,533 -35,371 -54,724 -23,678 -22,887 -21,844 47.20%
Tax 0 -2,379 0 0 0 -807 0 -
NP -38,992 77,533 -35,371 -54,724 -23,678 -22,887 -21,844 47.20%
Tax Rate - 3.07% - - - - - -
Total Cost 43,197 48,143 36,566 56,372 24,319 168,036 21,844 57.61%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -927.28 61.69 -2,959.92 -3,320.63 -3,693.92 -15.77 0.00 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.41 0.82 -0.38 -0.59 -0.26 -0.74 -0.27 32.14%
EPS Diluted -0.41 0.79 -0.38 -0.59 -0.26 -0.74 -0.27 32.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.